Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.63+0.58 (+1.38%)
At close: 4:00PM EDT
42.63 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close42.05
Open41.99
Bid38.20 x 800
Ask60.00 x 1200
Day's Range41.42 - 42.65
52 Week Range32.04 - 48.37
Volume29,516
Avg. Volume67,496
Market Cap613.501M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-1.89
Earnings DateMay 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.67
  • GlobeNewswire

    Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021

    BEDFORD, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2021 financial results after the close of the market on Thursday, November 4, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-800-437-239

  • GlobeNewswire

    Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting

    Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist arthritis and an alternative to wrist fusionBEDFORD, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced its WristMotion® Total Wrist Arthroplasty (TWA) System was launched at the American Society for Surgery of the Hand (ASSH) 2021 annual meeting in San Francisco, C

  • GlobeNewswire

    Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation

    510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixationBEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received an additional 510(k) clearance by the FDA for Tactoset® Injectable Bone Substitute. This new indication expands the use of Tactoset to include augmentation of hardware and the support of bone fragments d

Advertisement
Advertisement